Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Alter Verler Str. 1, Bielefeld, 33689, DE
The model aims to accelerate discovery and development of new Aramchol-based therapeutic approaches.
By: Patrick Lavery
By: Tim Wright
Delivers up to two-fold higher protein expression, three-fold increase in productivity.
By: Charlie Sternberg
Advances in payload-linker technology have made ADCs a major therapeutic modality, prompting drug developers to strive for greater selectivity and safety in the next wave of ADCs. Payload-linker selection is vital to these initiatives, making the choice of an experienced development and manufacturing partner a key decision in the highly competitive ADC market.
Released By Piramal Pharma Solutions
Chondros will oversee clinical development, clinical operations, medical affairs, and translational strategy.
Suitable for storing and administering highly sensitive biologics, including cell and gene therapies, biosimilars, and emergency medications.
By: Kristin Brooks
Represents an important addition to the therapeutic options for patients who struggle to meet LDL-C targets with existing treatments.
CHOMax’s approximate 10-month timeline is based on suitable, standard IgG monoclonal antibodies.
Aubuchon will lead commercialization strategy for VK2735, Viking’s potential best-in-class GLP-1/GIP dual agonist.
As data volumes accelerate, AI is becoming deeply embedded in safety operations and local qualified persons for PV are emerging as anchors of oversight.
By: Ana Pedro Jesuíno
Alliance combines high performing CHO-MK cells and GMP-manufactured culture media.
Introduces Simplist Ephedrine Sulfate Injection, USP and Simplist Succinylcholine Chloride Injection, USP.
Designed to increase titers and enhance bioprocessing performance of insulin-dependent CHO cell lines.
Sharon Mates, Charles Kunsch, & Pascal Touchon will help shape strategic vision, leadership, and company impact.
By: Rachel Klemovitch
Provides greater choice and flexibility for spectral flow cytometry in immunology research.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
